Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Thompson, A. M., Rea, D. W., Stos, P. M., Shepherd, L. E., Stambolic, V., & Parulekar, W. R. (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology, 41(35), 5356–5362. https://doi.org/10.1200/jco.23.00296
Subjects:
Breast Neoplasms
(MeSH)
Metformin
(MeSH)
Role of AMP-Activated Protein Kinase in Cellular Metabolism
(OpenAlex Topic)
Impact of Obesity on Cancer Risk and Prognosis
(OpenAlex Topic)
The p53 Signaling Network in Cancer Research
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1200/jco.23.00296
PMID:
DOI:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: